 | • レポートコード：D-MOR01037 • 出版社/出版日：Mordor Intelligence / 2019年12月26日 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：バイオ |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Multi User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Global Site License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートはバイオインフォマティクスについて総合的に分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品およびサービス別（知識管理ツール、バイオインフォマティクスプラットフォーム、バイオインフォマティクスサービス）分析、用途別（微生物ゲノム、遺伝子工学、医薬品開発、個別化医療、オミックス、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東およびアフリカ）分析、競争状況、市場機会および将来動向に区分して収録しています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・バイオインフォマティクスの世界市場：製品およびサービス別（知識管理ツール、バイオインフォマティクスプラットフォーム、バイオインフォマティクスサービス） ・バイオインフォマティクスの世界市場：用途別（微生物ゲノム、遺伝子工学、医薬品開発、個別化医療、オミックス、その他） ・バイオインフォマティクスの世界市場：地域別（北米、ヨーロッパ、アジア太平洋、中東およびアフリカ） ・競争状況 ・市場機会および将来動向 |
Bioinformatics Market – Growth, Trends, and Forecast (2019 – 2024)
Market Overview
The propelling factors for the growth of the global bioinformatics market include the increasing demand for nucleic acid and protein sequencing, increasing initiatives from government and private organizations, accelerating growth of proteomics and genomics, and increasing research on molecular biology and drug discovery. Owing to the aforementioned factors, the global bioinformatics market is expected to experience a boost during the forecast period.
Bioinformatics is gaining importance, as large amounts of data generated through techniques, like nucleic acid and protein sequencing, require data management and interpretation for future researches and medical purposes. Hence, increasing demand is expected to drive the bioinformatics market during the forecast period.
The demand for differentially expressed genes, computational epigenetics, meta-analysis of microarray data, gene network, systems biology requirements, and gene-associating studies, among others, has had a major impact on the growth of the global bioinformatics market.
Thus, technical advancements, along with the advent of the NGS technology, have helped in the development of bioinformatics tools for analyzing a great amount of data. This has contributed to the growth of the global bioinformatics market.
There is also little research that has been done in the field of bioinformatics to expedite decision-making in healthcare. Within clinical or medical informatics, there is a rich history of research on systems designed to help care providers and patients (healthcare consumers) and make optimal decisions surrounding diagnosis and management.
Scope of the Report
As per the scope of the report, bioinformatics is the application of computational technology to gather, store, analyze, and integrate biological data. This data is used to procure information and is applied to gene-based drug discovery and development, protein structure studies, and the determination of the therapeutic efficacy of drugs.
Key Market Trends
Personalized Medicine is the Segment under Application that is Expected to Grow the Fastest During the Forecast Period
Bioinformatics is an essential component in basic research and in the development of new concepts for diagnosis and therapy, as well as in clinical practice, in which these concepts are applied to treat patients. Some of the major drivers that help in the increasing demand for bioinformatics are, growing applications of bioinformatics in drug discovery and development and growing bioinformatics support in the development of personalized medicines and clinical diagnostics.
Asia-Pacific Holds the Fastest Growth and is Expected to Follow the Same Trend over the Forecast Period
A large number of healthcare investments in the Asia-Pacific region are expected to drive the bioinformatics market. Furthermore, the high adoption of IoT technologies in this sector is expected to impact market growth in the region positively. Key countries, including China and India, are expected to propel the bioinformatics market in this region mainly.
Competitive Landscape
Many pharmaceutical companies are minimizing drug discovery budgets, as they are shifting their focus from outsourcing of the software to developing in-house tools, thus allowing them to customize their required applications to meet their needs and increasing workflow efficiency. The major global players in the bioinformatics market include Illumina, Thermo Fisher Scientific, and Agilent Technologies, among others.
Reasons to Purchase this report:
The market estimate (ME) sheet in Excel format
Report customization as per the client’s requirements
3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Demand for Nucleic Acid and Protein Sequencing
4.2.2 Increasing Initiatives from Governments and Private Organizations
4.2.3 Accelerating Growth of Proteomics and Genomics
4.2.4 Increasing Research on Molecular Biology and Drug Discovery
4.3 Market Restraints
4.3.1 Lack of Well-defined Standards and Common Data Formats for Integration of Data
4.3.2 Data Complexity Concerns and Lack of User-friendly Tools
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product and Services
5.1.1 Knowledge Management Tools
5.1.2 Bioinformatics Platform
5.1.2.1 Interventional/Surgical Simulators
5.1.2.2 Sequence Analysis Platform
5.1.2.3 Sequence Alignment Platform
5.1.2.4 Sequence Manipulation Platform
5.1.2.5 Structural and Functional Analysis Platform
5.1.2.6 Other Bioinformatics Platforms
5.1.3 Bioinformatics Services
5.1.3.1 Sequencing Services
5.1.3.2 Database and Management Services
5.1.3.3 Data Analysis
5.1.3.4 Other Bioinformatics Services
5.2 By Application
5.2.1 Microbial Genome
5.2.2 Gene Engineering
5.2.3 Drug Development
5.2.4 Personalized Medicine
5.2.5 Omics
5.2.6 Other Applications
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Illumina Inc.
6.1.2 Life Technologies (Thermo Fischer Scientific)
6.1.3 Qiagen NV
6.1.4 Agilent Technologies
6.1.5 PerkinElmer
6.1.6 ABM
6.1.7 Accelrys Inc.
6.1.8 Geneva Bioinformatics SA
6.1.9 Ontoforce
6.1.10 Data4Cure
6.1.11 Life Map Sciences (Biotime)
7 MARKET OPPORTUNITIES AND FUTURE TRENDS